Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Chen

Showing results (251-260 of 256) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 256 results.
Journal of Cell Science|November 6, 2024
Decreased DNA density is a better indicator of a nuclear bleb than lamin B lossSamantha Bunner, Kelsey Prince, Emily M Pujadas Liwag, et al.
Molecular Cancer Therapeutics|February 1, 2015
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor ModelsPaul Foster, Kyoko Yamaguchi, Pin P Hsu, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitorsMoon H Kim, Amy Lew Tsuhako, Erick W Co, et al.
Journal of Medicinal Chemistry|December 19, 2022
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates <i>In Vivo</i> Antitumor ActivityJim Li, Lijing Chen, Roland J Billedeau, et al.
Nature Communications|September 9, 2022
In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy responseAditi Sahu, Kivanc Kose, Lukas Kraehenbuehl, et al.
JACC. Asia|March 21, 2026
Myocardial Infarction Without Standard Modifiable Risk Factors From 2025-2040: Forecast Analysis of Multinational, Population-Based StudyGrace Cao, Nicholas Weight, Silingga Metta Jauhari, et al.
Pageof 26

Showing results (251-260 of 256) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 256 results.
Journal of Cell Science|November 6, 2024
Decreased DNA density is a better indicator of a nuclear bleb than lamin B lossSamantha Bunner, Kelsey Prince, Emily M Pujadas Liwag, et al.
Molecular Cancer Therapeutics|February 1, 2015
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor ModelsPaul Foster, Kyoko Yamaguchi, Pin P Hsu, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitorsMoon H Kim, Amy Lew Tsuhako, Erick W Co, et al.
Journal of Medicinal Chemistry|December 19, 2022
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates <i>In Vivo</i> Antitumor ActivityJim Li, Lijing Chen, Roland J Billedeau, et al.
Nature Communications|September 9, 2022
In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy responseAditi Sahu, Kivanc Kose, Lukas Kraehenbuehl, et al.
JACC. Asia|March 21, 2026
Myocardial Infarction Without Standard Modifiable Risk Factors From 2025-2040: Forecast Analysis of Multinational, Population-Based StudyGrace Cao, Nicholas Weight, Silingga Metta Jauhari, et al.
Pageof 26